Skip to Content


Home > Paranormal news 2013 > Fighting the $9B ghost of Lipitor past, Pfizer points to new drugs - FiercePharma

< Previous | Next >

Fighting the $9B ghost of Lipitor past, Pfizer points to new drugs - FiercePharma

http://www.fiercepharma.com/story/fighting-9b-ghost-lipitor-past-pfizer-points-new-drugs/2013-01-29

Pfizer ($PFE) racked up a 46% increase in full-year profits. But its sales fell 10%. How so? Pfizer's sale of the nutrition business, which went to Nestle for $11.85 billion, helped boost reported net income to $14.57 billion. It also helped that 2011 ...

Submitted in section: Paranormal news 2013: Fighting the $9B ghost of Lipitor past, Pfizer points to new drugs - FiercePharma

Review It Rate It Bookmark It